Cilgavimab Recruiting Phase 3 Trials for Coronavirus Disease 2019 (COVID‑19) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT05321394Non-inferiority Trial on Treatments in Early COVID-19